MedPath

Does Cervical Pessary Prevent Spontaneous Preterm Birth in Twin Pregnancies With Short Cervical Length?

Not Applicable
Conditions
Preterm Birth
Interventions
Device: Cervical pessary
Registration Number
NCT02708264
Lead Sponsor
Federico II University
Brief Summary

Spontaneous preterm birth (SPTB) remains the number one cause of perinatal mortality in many countries, including the United States. Multiple gestations are at increased risk of SPTB. A short cervical length (CL) on transvaginal ultrasound (TVU) has been shown to be a good predictor of SPTB, in both singletons and twins.

The cervical pessary is a silicone device that has been used to prevent SPTB. The efficacy of the cervical pessary has been assessed in several populations including singletons with short CL, unselected twins, twins with short CL, and triplet pregnancies. Several randomized clinical trials (RCTs) have been published, and several are ongoing. However, no consensus on use of the cervical pessary in pregnancy or guidelines for management have been assessed.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
242
Inclusion Criteria
  • 18-50 years of age
  • Twin pregnancy (limits the participants to female gender)
  • Short cervical length (less than or equal to 30 mm) on second trimester ultrasound at 18-23 6/7 weeks gestation
Exclusion Criteria
  • Singleton or higher order than twins multiple gestation
  • Monoamniotic twins
  • Twin twin transfusion syndrome
  • Ruptured membranes
  • Lethal fetal structural anomaly
  • Fetal chromosomal abnormality
  • Cerclage in place (or planned placement)
  • Vaginal bleeding
  • Suspicion of chorioamnionitis
  • Ballooning of membranes outside the cervix into the vagina
  • Painful regular uterine contractions
  • Labor
  • Placenta previa

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cervical PessaryCervical pessaryThe cervical pessary is a silicone device that has been used to prevent SPTB Pessary will be placed between 18 and 23 6/7 weeks gestation, and will be removed during the 36th week of pregnancy (or earlier if indicated)
Primary Outcome Measures
NameTimeMethod
Spontaneous Preterm delivery <34 weeksLess than 34 weeks gestation
Secondary Outcome Measures
NameTimeMethod
Spontaneous rupture of membranesLess than 34 weeks gestation

Rupture of membranes \<34 weeks

Type of delivery (if cesarean or operativa vaginal or spontaneous vaginal delivery)Time of delivery

cesarean delivery, operative vaginal delivery, spontaneous vaginal delivery

Composite perinatal outcomeBetween birth and 28 days of age

Includes necrotizing enterocolitis, intraventricular hemorrhage (grade 3 or higher), respiratory distress syndrome, bronchopulmonary dysplasia (BPD), retinopathy, blood-culture proven sepsis and neonatal death

Birth weightTime of delivery
Gestational ageTime of delivery
Spontaneous preterm birth rates <37, <28 and <24 weeksLess than 24, 28, 34 and 37 weeks gestation
Neonatal deathBetween birth and 28 days of age
Maternal side effectsMaternal side effects

Trial Locations

Locations (1)

Gabriele Saccone

🇮🇹

Napoli, Italy

© Copyright 2025. All Rights Reserved by MedPath